跳至主要内容
临床试验/CTRI/2024/04/066437
CTRI/2024/04/066437尚未招募不适用

A Clinical Study to evaluate the 24 hours moisturization potential of Aqualogica Barrier Repair Moisturizer.

Honasa Consumer Ltd.1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2024年5月10日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
36
试验地点
1
主要终点
To study the skin hydration

研究概览

简要总结

A single blind one arm study.

Each participant entering the trial will be assigned to a regimen of investigational product, and advised to take general precautions as needed.

Subjects will be on study for 24hrs.

**Screening & Assigning:**Day 0

Test Product: Aqualogica Barrier Repair Moisturizer

Dose: Gently massage approx. 2-3 drop of serum over one block

Route of Administration: Topical

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 40.00 Year(s)(—)

入选标准

  • 1.Gender: Male or Female 18 to 40 2.Subjects willing to give written informed consent 3.Women of child bearing potential must have a negative urine pregnancy test prior to study entry.
  • 4.Are free of any systemic or dermatologic disorder, which, in the opinion of the investigator, will interfere with the study results or increase the risk of adverse events.
  • 5.Are willing to avoid prolonged exposure of the treatment area 5.To ultraviolet radiation (natural or artificial) for the duration of the study.

排除标准

  • 1.Subjects who are pregnant, breast-feeding, or planning to become pregnant during the study.
  • 2.Have any evidence of systemic cancer, squamous cell carcinoma, basal cell carcinoma, in the last 5 years, or any other confounding skin condition.
  • 3.Have open sores or open lesions in the treatment area(s).
  • 4.Have any condition that, in the opinion of the investigator, would confound the safety and/or efficacy assessments of the product.
  • 5.Have participated in any interventional clinical trial in the previous 90 days.
  • 6.Have a known sensitivity to any of the constituents of the test product 7.Have used, are using, or are planning to use immunosuppressive or immunomodulatory medication (i.e., biologics), including corticosteroids.
  • 8.Have not skin related issues.

结局指标

主要结局

To study the skin hydration

时间窗: At T0, T+30Min, T+2hrs, T+4hrs, T+6hrs, T+8hrs, T+24hrs

次要结局

  • To study the safety and tolerability(At T0 and 24 hrs)

研究者

发起方
Honasa Consumer Ltd.
申办方类型
Pharmaceutical industry-Indian
责任方
Principal Investigator
主要研究者

Dr Robin Chugh

CCFT Laboratories

研究点 (1)

Loading locations...

相似试验